1. The REMAR (Rhein-Main-Registry)-Study: Prospective evaluation of oncotype DX® Assay in Addition to Ki-67 for adjuvant treatment decisions in early breast cancer. (October 2020) Authors: Thill, M.; Anastasiadou, L.; Solbach, C.; Möbus, V.; Baier, P.; Ackermann, S.; Giesecke, D.; Schulmeyer, E.; Gabriel, B.; Mosch, D.; Buchen, S.; Krapfl, E.; Hurst, U.; Vescia, M.; Tesch, H.; Aulmann, S.; Jackisch, C. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗